Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut-associated lymphoid tissue (GALT) represents the largest component of the human immune system and serves as a critical interface between the host and the external environment of the gastrointestinal tract (StatPearls, 2023). It consists of specialized structures like Peyer's patches and isolated lymphoid follicles, which are populated by immune cells such as T cells, B cells, and dendritic cells that coordinate mucosal immunity and maintain tolerance to commensal flora (Nature Reviews Immunology, 2013). Pattern-recognition receptors (PRRs), including Toll-like receptors (TLRs) and NOD-like receptors (NLRs), are expressed on these immune cells and intestinal epithelia to sense pathogen-associated molecular patterns (PAMPs) and initiate innate and adaptive immune responses (PubMed, 2021). Dysregulation of GALT immune responses or PRR signaling is a central driver in the pathogenesis of chronic inflammatory conditions like Crohn's disease and ulcerative colitis (Journal of Clinical Investigation, 2017). Therapeutic strategies targeting this system include blocking the homing of lymphocytes to the GALT using integrin inhibitors or modulating specific PRR pathways to restore intestinal homeostasis (Frontiers in Immunology, 2020).
Modulation of mucosal immune responses through cytokine neutralization, inhibition of leukocyte trafficking to the gut (e.g., via integrin antagonism), or activation/antagonism of pattern-recognition receptors to stimulate or suppress innate signaling.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut-associated lymphoid tissue immune cells and pattern-recognition receptors.